-
Lifestyle and dietary modifications are important tools for both prevention and adjunctive treatment of hypertension, an important risk factor for cardiovascular disease, the leading cause of death for women.
-
Mention obesity or the need to lose weight, and the next thing to be brought up in many discussions is exercise. Either intuitively, or because of the attention this topic receives, many believe they are not getting enough exercise.
-
-
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
-
Do patients with diabetes share in the reduction of cardiovascular (CV) risk factors as much as non-diabetics?
-
Dual antiplatelet therapy with aspirin and clopidogrel has become the standard of care for patients suffering an acute coronary syndrome (ACS). However, there remains a significant incidence of recurrent ACS and mortality even in patients treated with dual antiplatelet therapy.
-
The ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) series of randomized, controlled trials has assessed the role of atorvastatin loading prior to percutaneous coronary intervention (PCI) in both stable and unstable coronary syndromes.
-
-
Folke et al from Copenhagen, Denmark, studied the consequences of automatic external defibrillator (AED) placement in a large metropolitan area.
-
Current recommendations for stroke prophylaxis with warfarin for patients with atrial fibrillation do not take into account the risks of hemorrhage.